Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

NCT01039428 is registered in ClinicalTrials.gov with KDL Inc. as lead sponsor.

NCT NCT01039428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01039428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Lead sponsor
KDL Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
June 30, 2010
Enrollment
68 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hyperphosphatemia